The Immunoscore (IS) is a measurement of CD3+ and CD8+ infiltrates in the tumor center and the invasive margin and was first validated as a prognostic biomarker in non-metastatic colon cancer [118]. The gene discussed is CD8A; the disease is neoplasm.